Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nexium safe for children

This article was originally published in The Tan Sheet

Executive Summary

FDA approves the use of AstraZeneca's prescription proton pump inhibitor Nexium (esomeprazole) for short-term treatment of children 1 to 11 years old for gastroesophageal reflux disease, the agency announces Feb. 28. Providers now can prescribe 10 mg to 20 mg daily doses for children 1 to 11 years old - half of the approved range for 12- to 17-year-olds, FDA says. The agency granted the approval after pediatric safety and pharmacokinetic studies revealed Nexium helped heal esophageal erosions after eight weeks of treatment...

Related Content

Prilosec OK for young children





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts